GeekWire August 14, 2024
In a laboratory near downtown Seattle on the shores of Lake Union, Hetu Kamisetty is helping build what he says is the biotech company of the future.
If talent, money and novel technology are any indication, he and his colleagues have a good shot at it.
Kamisetty heads the Seattle location of Xaira Therapeutics, an AI-focused startup launched in April with more $1 billion from investors.
The lab is populated by researchers skimmed from the nearby Institute for Protein Design, the lauded University of Washington research hub and spinout machine.
The founding members of Xaira’s molecule design and AI team, which Kamisetty leads, are all IPD alums.
Nathaniel Bennett helped develop RFDiffusion, an AI-powered tool from the IPD used to...